PATENT CLAIM ANALYSIS

Application Number: 16240673
Application Type: Utility
Filing Date: 2019-01
Publication Date: 2019-07
Patent Classification: ["514", "178000"]

Abstract:
Disclosed herein are compounds for the treatment of neurodegenerative diseases and compositions comprising the same.

Claim (Index 5):
The method of  claim 4 , wherein the neurodegenerative disease is selected from Alzheimer's Disease (AD) and Huntington's Disease.

Metadata:
- Claim Count in Document: 13.0
- Percentile: 99.0
- Lexical Diversity: 1.06667
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15666503', '12312543', '14978964', '15323552', '14336634']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7618539773678817
- 35 USC 102 Novelty (BERT): 0.4987567043927827
- Combined Prediction Score: 0.7355442500703719
- Mean Citation Score: 195.090478
- Max Citation Score: 208.21414
- Similarity Product: 136.72231476672408

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test